Skip to main content
Clinical Trials/CTRI/2020/06/025694
CTRI/2020/06/025694
Not yet recruiting
Phase 2

A comparative study of intravenous Fentanyl, Nalbuphine and Butorphanol on hemodynamic stress response to intubation and post-operative analgesia in modified radical mastectomy- A prospective randomized control study.

Beas Mukherjee0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: C50- Malignant neoplasm of breastHealth Condition 2: C50- Malignant neoplasm of breast
Sponsor
Beas Mukherjee
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Beas Mukherjee

Eligibility Criteria

Inclusion Criteria

  • Female patients with breast carcinoma posted for modified radical mastectomy aged between 18\-65 years ,giving valid informed consent belonging to ASA I and II.

Exclusion Criteria

  • Patient refusal or patients in ASA III or IV grade or having history of allergy to opioid group of drugs.

Outcomes

Primary Outcomes

Not specified

Similar Trials